Netopia Group has sold Web2SMS, its SMS messaging business, to Norway-based communications platform as a service (CPaaS) provider Link Mobility. The transaction values Web2SMS at an enterprise value ...

Netopia AI teams up with Globe’s venture builder 917Ventures to scale Predikta, a behavioral AI platform designed to predict public response before brands launch campaigns. For brands and ...

Axel Kornerup, MA, CEO/Co-Founder, Netopia; and Vince Yamat, President & CEO, 917Ventures THE Globe Group is reinforcing its role as an innovation platform by connecting startups with real enterprise ...

This content is being maintained for reference purposes but is not being updated. Netopia manufacture a variety of connection devices for various platforms, ranging from a standard dialup router ...

The Globe Group is reinforcing its role as an innovation platform by connecting startups with real enterprise environments, helping emerging technologies move beyond pilots to large-scale deployment.

Globe’s venture building arm, Velocity by 917Ventures announces Netopia AI as its pioneer startup after evaluating over 200 startups for enterprise alignment. Netopia AI’s behavioral AI product, ...

Netopia AI joins Velocity by 917Ventures, the venture building arm of Globe. Identified from a global pipeline of over 200 startups evaluated for enterprise alignment, Netopia AI will integrate with ...

Netopia AI recently announced that it is joining Velocity by 917Ventures by Globe to help scale up Predikta, the company’s behavioral AI platform. For those unfamiliar, Velocity by 917Ventures is the ...

Netopia AI, a pioneering behavioral AI startup behind Predikta, becomes the pioneer startup to formally join Velocity by 917Ventures, the venture building arm of Globe. Netopia AI will integrate with ...

ITWeb TV Live #SS25 Bernard Chadenga, The Cimplicity Institute Recorded live on the sidelines of the ITWeb Security Summit 2025, Bernard Chadenga founder and CEO, The Cimplicity Institute, chatted to ...

The Food and Drug Administration (FDA) has approved Cimzia to treat certain inflammatory conditions in adults, including rheumatoid arthritis. It’s also FDA approved for polyarticular juvenile ...